Substituted pyridinones as MGAT2 inhibitors
The present invention provides compounds of Formula (I): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, or a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.
Bristol-Myers Squibb Company
C A A A C C C A C C A A C C C C A C C A A C
C07D A61K A61P A61P C07D C07D C07D A61K C07D C07D A61P A61K C07D C07D C07D C07D A61P C07D C07D A61K A61K C07D
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Fang Wei James Pratik
Moore Wang Mignone Devasthale